Pancreatic Cancer Research

ResearcherUniversity of Southern CaliforniaActive in the last 2 years

Ba X. Hoang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2712-9747; OpenAlex author ID A5004476964. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. Dimensional Priming Reprograms Adipose-Derived Stromal Cells to Promote Pancreatic Cancer Progression. Last author DOI 10.3390/cancers18030460↗
  2. ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. Co-author DOI 10.3390/cancers17050870↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bo Han · 2 shared papers, 2025–2026 · strength 0.59
  2. Jamel Ali · 1 shared paper, 2026 · strength 0.36
  3. Thomas D. Schmittgen · 1 shared paper, 2026 · strength 0.36
  4. Sherise Chantell Rogers · 1 shared paper, 2025 · strength 0.24
  5. Shuqing Zhao · 1 shared paper, 2025 · strength 0.24
  6. Jonathan Barajas · 1 shared paper, 2025 · strength 0.24
  7. Edward Agyare · 1 shared paper, 2025 · strength 0.24
  8. Enrique I. Velazquez-Villarreal · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.